FDCP
IBDQ

Foster Dykema Cabot & Partners’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$252K – 375
2025
Q3 		$252K Hold
10,000
– – 0.02% 119
2025
Q2 		$252K Hold
10,000
– – 0.02% 113
2025
Q1 		$252K Sell
10,000
-3,100
-24% -$77.8K 0.02% 107
2024
Q4 		$328K Buy
13,100
+10,600
+424% +$266K 0.03% 101
2024
Q3 		$62.8K Buy
+2,500
New +$62.4K 0.01% 200

Other funds holding IBDQ

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Foster Dykema Cabot & Partners's IBDQ Position: Q4 2025 in Review

Foster Dykema Cabot & Partners sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 10,000 shares — an estimated $252K sold.

Foster Dykema Cabot & Partners first reported a position in IBDQ in Q3 2024 and held it in 5 quarters. The position peaked at $328K in Q4 2024. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Foster Dykema Cabot & Partners reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Foster Dykema Cabot & Partners sold 10,000 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $252K.
  • Foster Dykema Cabot & Partners first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q3 2024 and held it in 5 quarters.
  • Foster Dykema Cabot & Partners's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $328K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Foster Dykema Cabot & Partners's 13F filing for Q4 2025, filed 12 Feb 2026.